Logo image of BSX

BOSTON SCIENTIFIC CORP (BSX) Stock Price, Quote, News and Overview

NYSE:BSX - New York Stock Exchange, Inc. - US1011371077 - Common Stock - Currency: USD

101.1  -0.84 (-0.82%)

BSX Quote, Performance and Key Statistics

BOSTON SCIENTIFIC CORP

NYSE:BSX (1/27/2025, 11:47:10 AM)

101.1

-0.84 (-0.82%)

Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment
Statistics
52 Week High102.15
52 Week Low60.78
Market Cap149.00B
Shares1.47B
Float1.47B
Yearly Dividend0.02
Dividend YieldN/A
PE42.84
Fwd PE35.82
Earnings (Next)02-05 2025-02-05/amc
IPO05-19 1992-05-19


BSX short term performance overview.The bars show the price performance of BSX in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 10 20 30

BSX long term performance overview.The bars show the price performance of BSX in the last 1, 2 and 3 years. 1 year 2 years 3 years 20 40 60 80 100

The current stock price of BSX is 101.1 USD. In the past month the price increased by 13.44%. In the past year, price increased by 66.76%.

BOSTON SCIENTIFIC CORP / BSX Daily stock chart

BSX Latest News, Press Releases and Analysis

News Image
19 days ago - Chartmill

Which S&P500 stocks are moving on Wednesday?

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

News Image
19 days ago - Chartmill

Wondering what's happening in today's session for the S&P500 index? Stay informed with the top movers within the S&P500 index on Wednesday.

Let's have a look at what is happening on the US markets in the middle of the day on Wednesday. Below you can find the top S&P500 gainers and losers in today's session.

News Image
19 days ago - Chartmill

BOSTON SCIENTIFIC CORP (NYSE:BSX) showing some interesting technicals. Here's why.

In-Depth Technical Analysis of BOSTON SCIENTIFIC CORP.

News Image
11 days ago - Boston Scientific Corporation

Late-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation

/PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced data supporting the use of the FARAPULSEâ„¢ Pulsed Field Ablation (PFA) System* and the...

BSX Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES 27.6 223.53B
ISRG INTUITIVE SURGICAL INC 78.11 203.94B
SYK STRYKER CORP 34.08 151.22B
MDT MEDTRONIC PLC 17.42 117.29B
BDX BECTON DICKINSON AND CO 18.75 71.55B
GEHC GE HEALTHCARE TECHNOLOGY 21.08 40.64B
EW EDWARDS LIFESCIENCES CORP 25.69 40.45B
RMD RESMED INC 31.02 37.75B
IDXX IDEXX LABORATORIES INC 38.84 34.82B
DXCM DEXCOM INC 51.86 34.43B
PHG KONINKLIJKE PHILIPS NVR- NY 20.16 25.58B
ZBH ZIMMER BIOMET HOLDINGS INC 14.12 22.18B

About BSX

Company Profile

BSX logo image Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts and currently employs 48,000 full-time employees. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. The company also owns the transcarotid artery revascularization (TCAR) platform.

Company Info

BOSTON SCIENTIFIC CORP

300 Boston Scientific Way

Marlborough MASSACHUSETTS 01752 US

CEO: Michael F. Mahoney

Employees: 48000

Company Website: https://www.bostonscientific.com/en-US/Home.html

Investor Relations: https://investors.bostonscientific.com

Phone: 15086834000

BSX FAQ

What is the stock price of BSX?

The current stock price of BSX is 101.1 USD.


What is the symbol for BOSTON SCIENTIFIC CORP stock?

The exchange symbol of BOSTON SCIENTIFIC CORP is BSX and it is listed on the New York Stock Exchange, Inc. exchange.


On which exchange is BSX stock listed?

BSX stock is listed on the New York Stock Exchange, Inc. exchange.


Is BSX a good stock to buy?

Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for BSX, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of BSX.


Does BSX stock pay dividends?

BSX does not pay a dividend.


When does BSX stock report earnings?

BSX will report earnings on 2025-02-05, after the market close.


What is the Price/Earnings (PE) ratio of BSX?

The PE ratio for BSX is 42.84. This is based on the reported non-GAAP earnings per share of 2.36 and the current share price of 101.1 USD.


What is the Short Interest ratio of BSX stock?

The outstanding short interest for BSX is 0.99% of its float.


BSX Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to BSX. When comparing the yearly performance of all stocks, BSX is one of the better performing stocks in the market, outperforming 90.69% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

BSX Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to BSX. BSX has an excellent profitability rating, but there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

BSX Financial Highlights

Over the last trailing twelve months BSX reported a non-GAAP Earnings per Share(EPS) of 2.36. The EPS increased by 18.59% compared to the year before.


Industry RankSector Rank
PM (TTM) 11.27%
ROA 4.71%
ROE 8.66%
Debt/Equity 0.45
Chartmill High Growth Momentum
EPS Q2Q%26%
Sales Q2Q%19.34%
EPS 1Y (TTM)18.59%
Revenue 1Y (TTM)15.65%

BSX Ownership and Analysts

ChartMill assigns a Buy % Consensus number of 84% to BSX. The Buy consensus is the average rating of analysts ratings from 38 analysts.

For the next year, analysts expect an EPS growth of 21.26% and a revenue growth 17.63% for BSX


Ownership
Inst Owners92.66%
Ins Owners0.18%
Short Float %0.99%
Short Ratio2.74
Analysts
Analysts84.21
Price Target102.58 (1.46%)
EPS Next Y21.26%
Revenue Next Year17.63%